Phase I dose-escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma

BACKGROUND: Phase I trial was conducted to determine feasibility and toxicity of helical intensity-modulated radiotherapy (IMRT)-based stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma (HCC). RESULTS: Eighteen patients (22 lesions) were enrolled. With no DLT at 52 Gy (13 Gy/fraction...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jun Won, Seong, Jinsil, Lee, Ik Jae, Woo, Joong Yeol, Han, Kwang-Hyub
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130042/
https://www.ncbi.nlm.nih.gov/pubmed/27213593
http://dx.doi.org/10.18632/oncotarget.9450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130042/
https://www.ncbi.nlm.nih.gov/pubmed/27213593
http://dx.doi.org/10.18632/oncotarget.9450

Ejemplares similares